Investigation of human papillomavirus in bladder cancer in a series of Tunisian patients

Pathology Research and Practice

Volumn 206, Issue 11, 2010, Pages 740-743

  Selma, Walid Ben ^a   Ziadi, Sonia ^a   Gacem, Riadh Ben ^a   Amara, Khaled ^a   Ksiaa, Fériel ^a   Hachana, Mohamed ^a   Trimeche, Mounir ^a  

^a FARHAT HACHED HOSPITAL   (Tunisia)

Author keywords

Bladder cancer; Human papillomavirus; PCR

Indexed keywords

VIRUS DNA;

ADULT; AGED; ARTICLE; BLADDER CARCINOGENESIS; BLADDER CARCINOMA; CANCER GRADING; CANCER GROWTH; CANCER RISK; CLINICAL FEATURE; CONDYLOMA ACUMINATUM; CONTROLLED STUDY; DISEASE ASSOCIATION; DNA DETERMINATION; FEMALE; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; POLYMERASE CHAIN REACTION; PROCESS DEVELOPMENT; RETROSPECTIVE STUDY; SQUAMOUS CELL CARCINOMA; STRUCTURE ANALYSIS; TUMOR DIFFERENTIATION; TUNISIA; UROGENITAL TRACT CANCER; VIRUS CHARACTERIZATION; VIRUS DETECTION; WART VIRUS;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ALPHAPAPILLOMAVIRUS; ANUS DISEASES; CARCINOMA, SQUAMOUS CELL; CARCINOMA, TRANSITIONAL CELL; DNA, VIRAL; FEMALE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; POLYMERASE CHAIN REACTION; RETROSPECTIVE STUDIES; TUNISIA; URINARY BLADDER NEOPLASMS; UROTHELIUM;

EID: 77958463228     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.06.005     Document Type: Article

References (41)

1. Aggarwal S., Arora V.K., Gupta S., Singh N., Bhatia A. Koilocytosis: correlations with high-risk HPV and its comparison on tissue sections and cytology, urothelial carcinoma. Diagn. Cytopathol. 2009, 37:174-177.
2. Aynaud O., Tranbaloc P., Orth G. Lack of evidence for a role of human papillomaviruses in transitional cell carcinoma of the bladder. J. Urol. 1998, 159:86-90.
3. Badawi H., Ahmed H., Ismail A., Diab M., Moubarak M., Badawy A., et al. Role of human papillomavirus types 16, 18, and 52 in recurrent cystitis and urinary bladder cancer among Egyptian patients. Medscape J. Med. 2008, 10:232.
4. Bauer H.M., Ting Y., Greer C.E., Chambers J.C., Tashiro C.J., Chimera J., et al. Genital human papillomavirus infection in female university students as determined by a PCR-based method. JAMA 1991, 265:472-477.
5. Bhatia S., Louie A.D., Bhatia R., O'Donnell M.R., Fung H., Kashyap A., et al. Solid cancers after bone marrow transplantation. J. Clin. Oncol. 2001, 19:464-471.
6. Chan A.S., To K.F., Lo K.W., Mak K.F., Pak W., Chiu B., et al. High frequency of chromosome 3p deletion in histologically normal nasopharyngeal epithelia from Southern Chinese. Cancer Res. 2000, 60:5365-5370.
7. Chang F., Lipponen P., Tervahauta A., Syrjanen S., Syrjanen K. Transitional cell carcinoma of the bladder: failure to demonstrate human papillomavirus deoxyribonucleic acid by in situ hybridisation and polymerase chain reaction. J. Urol. 1994, 152:1429-1433.
8. De Villiers E.M., Lavergne D., McLaren K., Benton E.C. Prevalling papillomavirus types in non-melanoma carcinomas of the skin in renal allographt recipient. Int. J. Cancer 1997, 73:356-361.
9. Eble J.N., Sauter G., Epstein K.I., Sesterhenn I.A. Pathology and Genetics of Tumours of the Urinary System and Male Genital Organs 2004, World Health Organisation Classification of Tumours, International Agency for Research on Cancer Press, Lyon, p. 84.
10. Frisch M., Biggar R.J., Goedert J.J. Human papillomavirus-associated cancer in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J. Natl. Cancer Inst. 2000, 92:1500-1510.
11. Furihata M., Inoue K., Ohtsuki Y., Hashimoto H., Terao N., Fujita Y. High-risk human papillomavirus infections and overexpression of p53 protein as prognostic indicators in transitional cell carcinoma of the urinary bladder. Cancer Res. 1993, 53:4823-4827.
12. Halpert R., Fruchter R.G., Sedlis A., Butt K., Boyce J.G., Sillman F.H. Human papillomavirus and lower genital neoplasia in renal transplant patients. Obstet. Gynecol. 1986, 68:251-258.
13. Hermanek P., Hutter R., Sobin L.H., Wagner G., Wittekind C. TNM Classification des Tumeurs Malignes, Cinquième édition UICC 1997, Springer-Verlag, Paris, p. 96.
14. Josefsson A., Magnusson P., Gyllesten U. Detection and quantitation of human papillomavirus by using the fluorescent 5′ exonuclease assay. J. Clin. Microbiol. 1999, 37:490-496.
15. Khaled H.M., Bahnassi A.A., Zekri A.R., Kassem H.A., Mokhtar N. Correlation between p53 mutations and HPV in bilharzial bladder cancer. Urol. Oncol. 2003, 21:334-341.
16. Korbi S., Descotteaux C. Le Cancer Dans le Centre Tunisien 1993, Tunisie, pp. 1-117. Edition COPIE.
17. Koss L.G., Durfee G.R. Unsual patterns of squamous epithelium of the uterine cervix: cytologic and pathologic study of koïlocytic atypia. Ann. N. Y. Sci. 1956, 63:1245-1261.
18. Kurshid A., Naiki H., Nakakuki K., Inuzuka M. High frequency of human papillomavirus infection in carcinoma of the urinary bladder. Cancer 1992, 70:1967-1973.
19. LaRue H., Simoneau M., Fradet Y. Human papillomavirus in transitional cell carcinoma of the urinary bladder. Clin. Cancer Res. 1995, 1:435-440.
20. Maloney K.E., Wiener J.S., Walther P.J. Oncogenic human papillomavirus are rarely associated with squamous cell carcinoma of the bladder: evaluation by differential polymerase chain reaction. J. Urol. 1994, 151:360-364.
21. Moonen P.M., Bakkers J.M., Kiemeney L.A., Schalken J.A., Melchers W.J., Witjes J.A. Human papilloma virus DNA and p53 mutation analysis on bladder washes in relation to clinical outcome of bladder cancer. Eur. Urol. 2007, 52:464-469.
22. Nakamura Y., Mashima Y., Kameyama K., Mukai M., Oguchi Y. Detection of human papillomavirus infection in squamous tumours of the conjunctiva and lacrimal sac by immunohistochemistry, in situ hybridisation, and polymerase chain reaction. Br. J. Ophthalmol. 1997, 81:308-313.
23. Noel J.C., Thiry L., Verhest A., Deschepper N., Peny M.O., Sattar A.A., et al. Transitional cell carcinoma of the bladder: evaluation of the role of human papillomaviruses. Urology 1994, 44:671-675.
24. Querci della Rovere G., Oliver R.T., McCance D.J., Castro J.E. Development of bladder tumour containing HPV type 11 DNA after renal transplantation. Br. J. Urol. 1988, 62:36-38.
25. Raziuddin S., Shetty S., Ibrahim A., Patil K. Activated CD4-positive T-lymphocytes and impaired cell-mediated immunity in patients with carcinoma of the urinary bladder with schistosomiasis. Cancer 1990, 65:931-939.
26. Saltzstein D.R., Orihuela E., Kocurek J.N., Payne D.A., Chan T.S., Tyring S.K. Failure of the polymerase chain reaction (PCR) to detect human papilloma virus (HPV) in transitional cell carcinoma of the bladder. Anticancer Res. 1993, 13:423-426.
27. Scheffner M., Werness B.A., Huibregtse J.M., Levine A.J., Howley P.M. The E6 oncoprotein encoded by human papillomavirus types 16 and 18 promotes the degradation of p53. Cell 1990, 63:1129-1136.
28. Schlegel R., Phelps W.C., Zhang Y.L., Barbosa M. Quantitative keratinocyte assay detects two biological activities of human papillomavirus DNA and identifies viral types associated with cervical carcinoma. EMBO J. 1988, 7:3181-3187.
29. Silverberg E. Statistical and epidemiologic data on urologic cancer. Cancer 1987, 60:692-717.
30. Sur M., Cooper K., Allard U. Investigation of human papillomavirus in transitional cell carcinomas of the urinary bladder in South Africa. Pathology 2001, 33:17-20.
31. Tenti P., Zappatore R., Romagnoli S., Civardi E., Giunta P., Scelsi R., et al. p53 overexpression and human papillomavirus infection in transitional cell carcinoma of the urinary bladder: correlation with histological parameters. J. Pathol. 1996, 178:65-70.
32. Thomas M., Pim D., Banks L. The role of the E6-p53 interaction in the molecular pathogenesis of HPV. Oncogene 1999, 13:7690-7700.
33. Tungekar M.F., Al-Adnani M.S., Gatter K.C. Schistosomiasis associated with squamous lesions of the bladder: expression of low molecular weight cytokeratin proteins. Br. J. Urol. 1987, 60:423-427.
34. Van der Meijden A.P. Bladder cancer. BMJ 1998, 14:1366-1369.
35. Vousden K.H. Human papillomavirus transforming genes. Semin. Virol. 1991, 2:307-317.
36. Vousden K.H. Regulation of the cell cycle by viral oncoproteins. Semin. Cancer Biol. 1995, 6:109-116.
37. Woodworth C.D., Doniger J., DiPaolo J.A. Immortalization of human foreskin keratinocytes by various human papillomavirus DNAs corresponds to their association with cervical carcinoma. J. Virol. 1989, 63:159-164.
38. Youshya S., Purdie K., Breuer J., Proby C., Sheaf M.T., Oliver R.T., et al. Does human papillomavirus play a role in the development of bladder transitional cell carcinoma? A comparison of PCR and immunohistochemical analysis. J. Clin. Pathol. 2005, 58:207-210.
39. Zur Hausen H. Papillomavirus in ano-genital cancer as a model to understand the role of viruses in human cancer. Cancer Res. 1989, 489:4677-4681.
40. Zur Hausen H. Papillomavirus infections a major cause of human cancer. Biochim. Biophys. Acta 1996, 1288:55-78.
41. Zur Hausen H., de Villiers E.M. Human papillomaviruses. Annu. Rev. Microbiol. 1994, 48:427-447.